<?xml version="1.0" encoding="UTF-8"?>
<p>
 <xref rid="fig7" ref-type="fig">Figure 
  <xref rid="fig7" ref-type="fig">7</xref>
 </xref> reveals the distribution of patents among these vaccine types related to SARS and MERS. As can be seen, 15 patents disclose information about inactive and live-attenuated virus vaccines, 28 patents describe DNA vaccines, 21 patents disclose information on viral vector vaccines, 13 patents disclose information on VLP vaccines, and three patents are focused on mRNA vaccines.
</p>
